Skip to main content

Published locations for CDK4/6 inhibitors: Should they be stopped in the face of COVID-19?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CDK4/6 inhibitors: Should they be stopped in the face of COVID-19?

User login

  • Reset your password
  • /content/cdk4/6-inhibitors-should-they-be-stopped-face-covid-19
  • /internalmedicinenews/article/249640/metastatic-breast-cancer/cdk4/6-inhibitors-should-they-be
  • /oncologypractice/article/249640/metastatic-breast-cancer/cdk4/6-inhibitors-should-they-be-stopped
  • /hematology-oncology/article/249640/metastatic-breast-cancer/cdk4/6-inhibitors-should-they-be-stopped
  • /internalmedicine/article/249640/metastatic-breast-cancer/cdk4/6-inhibitors-should-they-be-stopped
  • /breast-cancer-icymi/article/249640/metastatic-breast-cancer/cdk4/6-inhibitors-should-they-be-stopped